Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Black Diamond Therapeutics (BDTX) Revenue (2025)

Black Diamond Therapeutics' Revenue history spans 1 years, with the latest figure at $70.0 million for Q1 2025.

  • For Q1 2025, Revenue changed N/A year-over-year to $70.0 million; the TTM value through Dec 2025 reached $70.0 million, changed N/A, while the annual FY2025 figure was $70.0 million, N/A changed from the prior year.
  • Revenue reached $70.0 million in Q1 2025 per BDTX's latest filing.
  • In the past five years, Revenue ranged from a high of $70.0 million in Q1 2025 to a low of $70.0 million in Q1 2025.